China will allow local government authorities to buy some homes at "reasonable" prices to provide affordable housing, Vice Premier He Lifeng told an online meeting on housing policy on Friday, the ... ( read original story ...)
Hong Kong, Shanghai stand out in Asia after China property move
Hong Kong and Shanghai stocks rallied Friday after China unveiled its most wide-ranging measures to support the country's battered property sector, sending real estate firms soaring. The move provided ... ( read original story ...)
Stock market today: Asian shares are mixed as China stocks get bump from new property measures
Asian shares are mixed after Chinese stocks reversed earlier losses following the announcement of fresh measures to revive the ailing property market Asian shares were ... Seng jumped 0.7% to 19,512.54 and the Shanghai Composite index surged 0.8% to ... ( read original story ...)
Stock market to be more efficiently regulated
As an important activity of the financial market, program trading can help stimulate market activity and improve liquidity. But it may also undermine market fairness and aggravate market volatility if lacking adequate supervision, said Chen Li, chief economist of Chuancai Securities. ( read original story ...)
Exclusive-Shanghai compiles data list eligible for faster overseas transfer, document shows
Shanghai has compiled a list of data that can be transferred overseas without security assessments, according to a government document seen by Reuters, a much anticipated move as China tries to lure ... ( read original story ...)
Shanghai Welcomes Over 310,000 Overseas Returnees as City Fosters Top Talent
(Yicai) May 17 -- Shanghai has attracted over 310,000 Chinese graduates back from abroad over the years as the eastern metropolis becomes a popular destination for young people wanting to start their ... ( read original story ...)
DN-1508052 by Shanghai De Novo Pharmatech for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
DN-1508052 is under clinical development by Shanghai De Novo Pharmatech and currently in Phase I for Recurrent Head And Neck Squamous Cell Carcinoma. ( read original story ...)